pISSN 2234-3806
eISSN 2234-3814
Cited by CrossRef (15)
- Kaaren K. Reichard, Adam J. Wood. Laboratory Test Utilization Management. Surgical Pathology Clinics 2016;9:1

- Maude Landry, Marc-Nicolas Bienz, Bassem Sawan, Rabia Temmar, Patrice Beauregard, Francis Chaunt, Jean Lavigne, Hans Knecht. Bone Marrow Immunohistochemistry and Flow Cytometry in the Diagnosis of Malignant Hematologic Diseases With Emphasis on Lymphomas: A Comparative Retrospective Study. 2020;28:508

- Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ha Nui Kim, Jung Ah Kwon, Soo‐Young Yoon, Jung Yoon. Assessment of Bone Marrow Involvement in B‐Cell non‐Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next‐Generation Sequencing. Clinical Laboratory Analysis 2024;38

- Xinyu Liang, Chunli Yang, Minggang Su, Liqun Zou.
Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [
18
F]FDG-PET/CT and bone marrow biopsy findings
. Current Medical Research and Opinion 2024;40:803

- M. A. Cabezas-Quintario, P. Gomez, V. Yuste-Del Pozo, A. L. Valencia-Mesa, G. Sosa, P. Ricard, A. I. Hijas-Gómez, F. Pinedo, M. Arguelles. Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution. Clin Transl Oncol 2016;18:537

- Marc Sorigue, Eloi Cañamero, Milos D. Miljkovic. Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry. Blood Reviews 2021;47:100778

- Yusuke Saiki, Naoto Tomita, Akiko Uchida, Yu Uemura, Yoshinori Suzuki, Tsuneaki Hirakawa, Masayuki Kato, Masahiro Hoshikawa, Tsuyoshi Kawano, Naoya Nakamura, Ikuo Miura, Ayako Arai. Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography. Int J Hematol 2021;113:675

- Uri Greenbaum, Itai Levi, Odelia Madmoni, Yotam Lior, Kayed Al-Athamen, Zvi Howard Perry, Lev Hatzkelzon, George Shubinsky. The prognostic significance of bone marrow involvement in diffuse large B cell lymphoma according to the flow cytometry. Leukemia & Lymphoma 2019;60:2477

- Anu Singh, Jagruti Patil, Sitaram G. Ghogale, Nilesh Deshpande, Karishma Girase, Navami Shetye, Sweta Rajpal, Gaurav Chatterjee, Nikhil Patkar, Disha Jain, Sridhar Epari, Tanuja Shet, Sumeet Gujral, Papagudi G. Subramanian, Prashant R. Tembhare. Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma. Cytometry Part B Clinical 2024;106:359

- Shimaa G. Mansour, Menna A.M. Atef Abdelaziz, Eman N.E. Mohammed, Douaa M. Sayed. Role of CD200 as diagnostic and prognostic marker for chronic lymphocytic leukemia. Egypt J Haematol 2024;49:265

- Wei Wang, Yan Li, Haval Ali, Linjun Zhao, Di Mei, Wenqing Hu, Bin Jiang. Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens. BMC Cancer 2021;21

- Yuliya A. Veryaskina, Sergei E. Titov, Igor B. Kovynev, Tatiana I. Pospelova, Igor F. Zhimulev. The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin’s Lymphomas. Diagnostics 2022;12:629

- Yin-Liang Tang, Chien-Yu Chiu, Chun-Yu Lin, Chung-Hao Huang, Yen-Hsu Chen, Raul Destura, Day-Yu Chao, Han-Chung Wu. Establishment and Comparison of Two Different Diagnostic Platforms for Detection of DENV1 NS1 Protein. IJMS 2015;16:27850

- Wei Wang, Yan Li, Xavier Rivera Rivera, Linjun Zhao, Di Mei, Wenqing Hu, Bin Jiang. Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma. BMC Cancer 2021;21

- Thulasi Raman Ramalingam, Anurekha Muthu, Archana Lakshmanan, Swetha Narla, Annapurneswari Subramanyan, Shelley Simon, Jayaraj Govindaraj, Lakshman Vaidhyanathan, Jose Easow, Thirumalairaj Raja. Role of high acquisition flow cytometry in the detection of marrow involvement in patients with extramedullary B cell non-Hodgkins lymphoma: a comparison with marrow aspirate cytology, trephine biopsy, and PET. Leukemia & Lymphoma 2022;63:2589
